Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
JAMA Netw Open. 2024 Jan 2;7(1):e2350424. doi: 10.1001/jamanetworkopen.2023.50424.
Fertility status is a marker for future health, and infertility has been associated with risk for later cancer and diabetes, but associations with midlife cardiovascular health (CVH) in female individuals remain understudied.
To evaluate the association of infertility history with CVH at midlife (approximately age 50 years) among parous individuals.
DESIGN, SETTING, AND PARTICIPANTS: Project Viva is a prospective cohort study of pregnant participants enrolled between 1999 and 2002 who delivered a singleton live birth in the greater Boston, Massachusetts, area. Infertility history was collected at a midlife visit between 2017 and 2021, approximately 18 years after enrollment. Data analysis was performed from January to June 2023.
The primary exposure was any lifetime history of infertility identified by self-report, medical record, diagnosis, or claims for infertility treatment.
The American Heart Association's Life's Essential 8 (LE8) is a construct for ranking CVH that includes scores from 0 to 100 (higher scores denote better health status) in 4 behavioral (diet, physical activity, sleep, and smoking status) and 4 biomedical (body mass index, blood pressure, blood lipids, and glycemia) domains to form an overall assessment of CVH. Associations of a history of infertility (yes or no) with mean LE8 total, behavioral, biomedical, and blood biomarker (lipids and glycemia) scores were examined, adjusting for age at outcome (midlife visit), race and ethnicity, education, household income, age at menarche, and perceived body size at age 10 years.
Of 468 included participants (mean [SD] age at the midlife visit, 50.6 [5.3] years) with exposure and outcome data, 160 (34.2%) experienced any infertility. Mean (SD) LE8 scores were 76.3 (12.2) overall, 76.5 (13.4) for the behavioral domain, 76.0 (17.5) for the biomedical domain, and 78.9 (19.2) for the blood biomarkers subdomain. In adjusted models, the estimated overall LE8 score at midlife was 2.94 points lower (95% CI, -5.13 to -0.74 points), the biomedical score was 4.07 points lower (95% CI, -7.33 to -0.78 points), and the blood subdomain score was 5.98 points lower (95% CI, -9.71 to -2.26 points) among those with vs without history of infertility. The point estimate also was lower for the behavioral domain score (β = -1.81; 95% CI, -4.28 to 0.66), although the result was not statistically significant.
This cohort study of parous individuals found evidence for an association between a history of infertility and lower overall and biomedical CVH scores. Future study of enhanced cardiovascular preventive strategies among those who experience infertility is warranted.
生育状况是未来健康的标志,不孕与日后癌症和糖尿病的风险增加有关,但在女性个体中,不孕与中年心血管健康(CVH)的关联仍研究不足。
评估在经历过生育的个体中,不孕史与中年(约 50 岁)CVH 的关联。
设计、地点和参与者:Viva 项目是一项前瞻性队列研究,参与者为 1999 年至 2002 年期间入组的已孕个体,这些参与者在马萨诸塞州大波士顿地区分娩了单胎活产儿。在 2017 年至 2021 年期间进行的中年访视中收集了不孕史,大约是入组后 18 年。数据分析于 2023 年 1 月至 6 月进行。
主要暴露是通过自我报告、医疗记录、诊断或不孕症治疗的索赔确定的任何终生不孕史。
美国心脏协会的生命必需 8 项(LE8)是一个用于对 CVH 进行排名的结构,包括 4 个行为(饮食、身体活动、睡眠和吸烟状况)和 4 个生物医学(体重指数、血压、血脂和血糖)领域的分数,从 0 到 100(分数越高表示健康状况越好),形成 CVH 的总体评估。检查了不孕史(是或否)与 LE8 总分、行为、生物医学和血液生物标志物(血脂和血糖)评分的平均分数之间的关联,调整了结局(中年访视)时的年龄、种族和民族、教育程度、家庭收入、初潮年龄和 10 岁时的身体大小感知。
在 468 名纳入的参与者(中年访视时的平均[SD]年龄,50.6[5.3]岁)中,有暴露和结局数据,160 名(34.2%)经历过不孕。LE8 总分的平均(SD)分数为 76.3(12.2),行为域为 76.5(13.4),生物医学域为 76.0(17.5),血液生物标志物子域为 78.9(19.2)。在调整模型中,与无不孕史者相比,中年时估计的整体 LE8 评分低 2.94 分(95%置信区间,-5.13 至-0.74 分),生物医学评分低 4.07 分(95%置信区间,-7.33 至-0.78 分),血液子域评分低 5.98 分(95%置信区间,-9.71 至-2.26 分)。尽管结果没有统计学意义,但行为域评分的点估计值也较低(β=-1.81;95%置信区间,-4.28 至 0.66)。
这项对经历过生育的个体的队列研究发现,不孕史与整体和生物医学 CVH 评分较低之间存在关联。需要进一步研究那些经历不孕的人增强心血管预防策略。